Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N, Ticchioni M, Duchange A, Morel-Mandrino P, Neveu V, Clerget-Chossat N, Forte M, Colombel JF.
Desreumaux P, et al.
Gastroenterology. 2012 Nov;143(5):1207-1217.e2. doi: 10.1053/j.gastro.2012.07.116. Epub 2012 Aug 8.
Gastroenterology. 2012.
PMID: 22885333
Clinical Trial.